171 related articles for article (PubMed ID: 10436816)
1. Somatostatin receptor imaging and therapy of pancreatic endocrine tumors.
van Eijck CH; de Jong M; Breeman WA; Slooter GD; Marquet RL; Krenning EP
Ann Oncol; 1999; 10 Suppl 4():177-81. PubMed ID: 10436816
[TBL] [Abstract][Full Text] [Related]
2. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
De Jong M; Breeman WA; Bernard HF; Kooij PP; Slooter GD; Van Eijck CH; Kwekkeboom DJ; Valkema R; Mäcke HR; Krenning EP
Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.
Slooter GD; Mearadji A; Breeman WA; Marquet RL; de Jong M; Krenning EP; van Eijck CH
Br J Surg; 2001 Jan; 88(1):31-40. PubMed ID: 11136306
[TBL] [Abstract][Full Text] [Related]
4. Peptide receptor imaging and therapy.
Kwekkeboom D; Krenning EP; de Jong M
J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002
[TBL] [Abstract][Full Text] [Related]
5. 111In-octreotide scintigraphy in oncology.
Krenning EP; Kwekkeboom DJ; Reubi JC; van Hagen PM; van Eijck CH; Oei HY; Lamberts SW
Digestion; 1993; 54 Suppl 1():84-7. PubMed ID: 8359573
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor imaging of endocrine gastrointestinal tumors.
Krenning EP; Kwekkeboom DJ; Oei HY; Reubi JC; van Hagen PM; Kooij PP; Reijs AE; Lamberts SW
Schweiz Med Wochenschr; 1992 Apr; 122(17):634-7. PubMed ID: 1350377
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver.
Slooter GD; Breeman WA; Marquet RL; Krenning EP; van Eijck CH
Int J Cancer; 1999 May; 81(5):767-71. PubMed ID: 10328231
[TBL] [Abstract][Full Text] [Related]
8. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
[TBL] [Abstract][Full Text] [Related]
9. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Banzo J; Abós MD; Prats E; García F; Razola P
Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
[No Abstract] [Full Text] [Related]
10. Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
Krenning EP; de Jong M; Kooij PP; Breeman WA; Bakker WH; de Herder WW; van Eijck CH; Kwekkeboom DJ; Jamar F; Pauwels S; Valkema R
Ann Oncol; 1999; 10 Suppl 2():S23-9. PubMed ID: 10399029
[TBL] [Abstract][Full Text] [Related]
11. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
Modlin IM; Cornelius E; Lawton GP
Arch Surg; 1995 Apr; 130(4):367-73; discussion 373-4. PubMed ID: 7710334
[TBL] [Abstract][Full Text] [Related]
12. OctreoScan 111 for imaging of a somatostatin receptor-positive islet cell tumor in rat.
Bruns C; Stolz B; Albert R; Marbach P; Pless J
Horm Metab Res Suppl; 1993; 27():5-11. PubMed ID: 8392488
[TBL] [Abstract][Full Text] [Related]
13. [The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Chiti A; Spinelli A; Bombardieri E
Radiol Med; 1997 Oct; 94(4):362-70. PubMed ID: 9465244
[No Abstract] [Full Text] [Related]
14. Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
de Jong M; Breeman WA; Bakker WH; Kooij PP; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt MA; Erion JL; Bugaj JE; Mäcke HR; Krenning EP
Cancer Res; 1998 Feb; 58(3):437-41. PubMed ID: 9458086
[TBL] [Abstract][Full Text] [Related]
15. The visualization of gastroenteropancreatic endocrine tumors.
Lamberts SW; Chayvialle JA; Krenning EP
Digestion; 1993; 54 Suppl 1():92-7. PubMed ID: 8395433
[TBL] [Abstract][Full Text] [Related]
16. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
[TBL] [Abstract][Full Text] [Related]
17. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
18. Somatostatin receptors and breast cancer.
van Eijck CH; Kwekkeboom DJ; Krenning EP
Q J Nucl Med; 1998 Mar; 42(1):18-25. PubMed ID: 9646641
[TBL] [Abstract][Full Text] [Related]
19. [Somatostatin-receptor imaging in endocrine tumors].
Krausz Y; Ish-Shalom S; Lapidot M; Glaser B
Harefuah; 1994 Jul; 127(1-2):36-9. PubMed ID: 7959388
[No Abstract] [Full Text] [Related]
20. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.
Scherübl H; Bäder M; Fett U; Hamm B; Schmidt-Gayk H; Koppenhagen K; Dop FJ; Riecken EO; Wiedenmann B
Gastroenterology; 1993 Dec; 105(6):1705-9. PubMed ID: 7902821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]